A few years back in 2007 Global Financial Insight were promoting another company - BodyTel Inc. (BDYT) which shares some striking similarities with BIZM. Both started out as shells, both of them signed joined ventures with German companies and both started hyping up some miraculous patented product. BDYT were supposed to create a significantly scaled-down blood glucose monitor that never saw the light of day. Ultimately they failed to generate any revenues and after reaching a peak of $3 per share have since fallen into obscurity.
If BIZM are going to follow the same route remains to be seen. Their handheld spectroscopic scanner has been attempted to be marketed at least twice already with no results. This time around they are accepting pre orders if you are willing to send them your information.
And don't forget the 20 million shares, adjusted after a 33-for-1 forward split, held by seed investors who bought them at $0.003 and that are now worth $74 million.